CD44 and cancer: Signaling born from the intracellular portion of CD44 activates Ras, MAPK, PI3K [500], and RUNX2-RANKL pathways [501].CD44 is a marker of cancer stem cells (CSCs) and regulates stemness [502,503,504,505].